Literature DB >> 21056975

Strong cross-bridges potentiate the Ca(2+) affinity changes produced by hypertrophic cardiomyopathy cardiac troponin C mutants in myofilaments: a fast kinetic approach.

Jose Renato Pinto1, Daniel P Reynaldo, Michelle S Parvatiyar, David Dweck, Jingsheng Liang, Michelle A Jones, Martha M Sorenson, James D Potter.   

Abstract

This spectroscopic study examined the steady-state and kinetic parameters governing the cross-bridge effect on the increased Ca(2+) affinity of hypertrophic cardiomyopathy-cardiac troponin C (HCM-cTnC) mutants. Previously, we found that incorporation of the A8V and D145E HCM-cTnC mutants, but not E134D into thin filaments (TFs), increased the apparent Ca(2+) affinity relative to TFs containing the WT protein. Here, we show that the addition of myosin subfragment 1 (S1) to TFs reconstituted with these mutants in the absence of MgATP(2-), the condition conducive to rigor cross-bridge formation, further increased the apparent Ca(2+) affinity. Stopped-flow fluorescence techniques were used to determine the kinetics of Ca(2+) dissociation (k(off)) from the cTnC mutants in the presence of TFs and S1. At a high level of complexity (i.e. TF + S1), an increase in the Ca(2+) affinity and decrease in k(off) was achieved for the A8V and D145E mutants when compared with WT. Therefore, it appears that the cTnC Ca(2+) off-rate is most likely to be affected rather than the Ca(2+) on rate. At all levels of TF complexity, the results obtained with the E134D mutant reproduced those seen with the WT protein. We conclude that strong cross-bridges potentiate the Ca(2+)-sensitizing effect of HCM-cTnC mutants on the myofilament. Finally, the slower k(off) from the A8V and D145E mutants can be directly correlated with the diastolic dysfunction seen in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056975      PMCID: PMC3020707          DOI: 10.1074/jbc.M110.168583

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C.

Authors:  Jonathan P Davis; Catalina Norman; Tomoyoshi Kobayashi; R John Solaro; Darl R Swartz; Svetlana B Tikunova
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

2.  Preparation of troponin and its subunits.

Authors:  J D Potter
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

3.  Calcium binding to the low affinity sites in troponin C induces conformational changes in the high affinity domain. A possible route of information transfer in activation of muscle contraction.

Authors:  Z Grabarek; P C Leavis; J Gergely
Journal:  J Biol Chem       Date:  1986-01-15       Impact factor: 5.157

4.  The effects of ADP and phosphate on the contraction of muscle fibers.

Authors:  R Cooke; E Pate
Journal:  Biophys J       Date:  1985-11       Impact factor: 4.033

5.  A fluorescent probe study of Ca2+ binding to the Ca2+-specific sites of cardiac troponin and troponin C.

Authors:  J D Johnson; J H Collins; S P Robertson; J D Potter
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

6.  Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice.

Authors:  Yuhui Wen; Jose Renato Pinto; Aldrin V Gomes; Yuanyuan Xu; Yingcai Wang; Ying Wang; James D Potter; W Glenn L Kerrick
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

7.  The effects of deletion of the amino-terminal helix on troponin C function and stability.

Authors:  L Smith; N J Greenfield; S E Hitchcock-DeGregori
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

8.  Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.

Authors:  Paul Robinson; Peter J Griffiths; Hugh Watkins; Charles S Redwood
Journal:  Circ Res       Date:  2007-10-11       Impact factor: 17.367

9.  Reciprocal coupling between troponin C and myosin crossbridge attachment.

Authors:  A S Zot; J D Potter
Journal:  Biochemistry       Date:  1989-08-08       Impact factor: 3.162

10.  The cardiac troponin C mutation Leu29Gln found in a patient with hypertrophic cardiomyopathy does not alter contractile parameters in skinned murine myocardium.

Authors:  Axel Neulen; Robert Stehle; Gabriele Pfitzer
Journal:  Basic Res Cardiol       Date:  2009-06-09       Impact factor: 17.165

View more
  17 in total

1.  The structure of the native cardiac thin filament at systolic Ca2+ levels.

Authors:  Cristina M Risi; Ian Pepper; Betty Belknap; Maicon Landim-Vieira; Howard D White; Kelly Dryden; Jose R Pinto; P Bryant Chase; Vitold E Galkin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

2.  A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.

Authors:  Michelle S Parvatiyar; Andrew P Landstrom; Cicero Figueiredo-Freitas; James D Potter; Michael J Ackerman; Jose Renato Pinto
Journal:  J Biol Chem       Date:  2012-07-18       Impact factor: 5.157

Review 3.  The myosin-activated thin filament regulatory state, M⁻-open: a link to hypertrophic cardiomyopathy (HCM).

Authors:  Sherwin S Lehrer; Michael A Geeves
Journal:  J Muscle Res Cell Motil       Date:  2014-04-17       Impact factor: 2.698

4.  Structural and functional impact of troponin C-mediated Ca2+ sensitization on myofilament lattice spacing and cross-bridge mechanics in mouse cardiac muscle.

Authors:  David Gonzalez-Martinez; Jamie R Johnston; Maicon Landim-Vieira; Weikang Ma; Olga Antipova; Omar Awan; Thomas C Irving; P Bryant Chase; J Renato Pinto
Journal:  J Mol Cell Cardiol       Date:  2018-08-21       Impact factor: 5.000

5.  Effect of hypertrophic cardiomyopathy-linked troponin C mutations on the response of reconstituted thin filaments to calcium upon troponin I phosphorylation.

Authors:  Acchia N J Albury; Nicholas Swindle; Darl R Swartz; Svetlana B Tikunova
Journal:  Biochemistry       Date:  2012-04-16       Impact factor: 3.162

6.  Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C.

Authors:  Henry G Zot; Javier E Hasbun; Clara A Michell; Maicon Landim-Vieira; Jose R Pinto
Journal:  Arch Biochem Biophys       Date:  2016-03-11       Impact factor: 4.013

7.  The intrinsically disordered C terminus of troponin T binds to troponin C to modulate myocardial force generation.

Authors:  Jamie R Johnston; Maicon Landim-Vieira; Mayra A Marques; Guilherme A P de Oliveira; David Gonzalez-Martinez; Adolfo H Moraes; Huan He; Anwar Iqbal; Yael Wilnai; Einat Birk; Nili Zucker; Jerson L Silva; P Bryant Chase; Jose Renato Pinto
Journal:  J Biol Chem       Date:  2019-11-20       Impact factor: 5.157

Review 8.  Biochemical characterisation of Troponin C mutations causing hypertrophic and dilated cardiomyopathies.

Authors:  Athanasia Kalyva; Fragiskos I Parthenakis; Maria E Marketou; Joanna E Kontaraki; Panos E Vardas
Journal:  J Muscle Res Cell Motil       Date:  2014-04-18       Impact factor: 2.698

9.  In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.

Authors:  Adriano S Martins; Michelle S Parvatiyar; Han-Zhong Feng; J Martijn Bos; David Gonzalez-Martinez; Milica Vukmirovic; Rajdeep S Turna; Marcos A Sanchez-Gonzalez; Crystal-Dawn Badger; Diego A R Zorio; Rakesh K Singh; Yingcai Wang; J-P Jin; Michael J Ackerman; Jose R Pinto
Journal:  Circ Cardiovasc Genet       Date:  2015-08-24

Review 10.  Structure and function of cardiac troponin C (TNNC1): Implications for heart failure, cardiomyopathies, and troponin modulating drugs.

Authors:  Monica X Li; Peter M Hwang
Journal:  Gene       Date:  2015-07-29       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.